FDA approves AZ’s Baxfendy (baxdrostat), first-in-class ASI for uncontrolled hypertension
Baxfendy 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline in BaxHTN trial.
Baxfendy 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline in BaxHTN trial.
These results reinforce the roles of IL-4 and IL-13, two of the key and central drivers of type 2 inflammation, in EoE.
The tariffs will come into effect in 120 days for certain large companies, and 180 days for smaller companies.
The collaboration leverages NationsBenefits’ Basket Adjudication Service (BAS) to enable seamless Flex Card acceptance across Kinney Drugs’ pharmacy and front‑of‑store environments.
Lawmkers and the White House delivered a ‘historic win’ for ‘the face of neighborhood care.’
One patient, one family, and one community at a time.
By Sandra Hanna, CEO of the Neighbourhood Pharmacy Association of Canada
By Ron Piervincenzi is CEO of U.S. Pharmacopeia.
By Michael Hogue, executive vice president and CEO of the American Pharmacists Association
By Susan Cantrell, CEO, Academy of Managed Care Pharmacy
By Scott Melville, president and CEO of the Consumer Healthcare Products Association
By Peter Matz, Director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
By Chester “Chip” Davis Jr. is president and CEO of the Healthcare Distribution Alliance
By Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy
By John Murphy III, president and CEO of the Association for Accessible Medicines